Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma.

作者信息

Salido Marta, Martinez-Avilés Luz, Ademà Vera, Ferrer Ana, Espinet Blanca, Garcia Mar, Salar Antonio, Besses Carles, Florensa Lourdes, Serrano Sergi, Bellosillo Beatriz, Solé Francesc

出版信息

Leuk Res. 2011 Mar;35(3):e23-4. doi: 10.1016/j.leukres.2010.10.014. Epub 2010 Nov 18.

DOI:10.1016/j.leukres.2010.10.014

PMID:21087793

Abstract

摘要

相似文献

Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma.

Leuk Res. 2011 Mar;35(3):e23-4. doi: 10.1016/j.leukres.2010.10.014. Epub 2010 Nov 18.

The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.

Leukemia. 2008 Jun;22(6):1268-72. doi: 10.1038/sj.leu.2405027. Epub 2007 Nov 8.

Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.

J Pathol. 2010 Mar;220(4):461-74. doi: 10.1002/path.2665.

EZH2 Y641 mutations in follicular lymphoma.

Leukemia. 2011 Apr;25(4):726-9. doi: 10.1038/leu.2010.311. Epub 2011 Jan 14.

High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.

Br J Haematol. 2012 Sep;158(6):712-26. doi: 10.1111/j.1365-2141.2012.09226.x. Epub 2012 Jul 23.

Splenic marginal zone lymphoma.

Best Pract Res Clin Haematol. 2017 Mar-Jun;30(1-2):56-64. doi: 10.1016/j.beha.2016.09.005. Epub 2016 Nov 5.

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies.

Leukemia. 2010 Oct;24(10):1799-804. doi: 10.1038/leu.2010.167. Epub 2010 Aug 19.

BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.

Haematologica. 2012 Apr;97(4):595-8. doi: 10.3324/haematol.2011.054080. Epub 2011 Nov 18.

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.

Clin Cancer Res. 2015 Sep 15;21(18):4174-4183. doi: 10.1158/1078-0432.CCR-14-2759. Epub 2015 Mar 16.

Aberrations of EZH2 in cancer.

Clin Cancer Res. 2011 May 1;17(9):2613-8. doi: 10.1158/1078-0432.CCR-10-2156. Epub 2011 Mar 2.

引用本文的文献

Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Curr Cancer Drug Targets. 2013 Jun;13(5):558-79. doi: 10.2174/1568009611313050007.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma.

Leuk Res. 2011 Mar;35(3):e23-4. doi: 10.1016/j.leukres.2010.10.014. Epub 2010 Nov 18.

The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.

Leukemia. 2008 Jun;22(6):1268-72. doi: 10.1038/sj.leu.2405027. Epub 2007 Nov 8.

Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.

J Pathol. 2010 Mar;220(4):461-74. doi: 10.1002/path.2665.

EZH2 Y641 mutations in follicular lymphoma.

Leukemia. 2011 Apr;25(4):726-9. doi: 10.1038/leu.2010.311. Epub 2011 Jan 14.

High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.

Br J Haematol. 2012 Sep;158(6):712-26. doi: 10.1111/j.1365-2141.2012.09226.x. Epub 2012 Jul 23.

Splenic marginal zone lymphoma.

Best Pract Res Clin Haematol. 2017 Mar-Jun;30(1-2):56-64. doi: 10.1016/j.beha.2016.09.005. Epub 2016 Nov 5.

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies.

Leukemia. 2010 Oct;24(10):1799-804. doi: 10.1038/leu.2010.167. Epub 2010 Aug 19.

BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.

Haematologica. 2012 Apr;97(4):595-8. doi: 10.3324/haematol.2011.054080. Epub 2011 Nov 18.

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.

Clin Cancer Res. 2015 Sep 15;21(18):4174-4183. doi: 10.1158/1078-0432.CCR-14-2759. Epub 2015 Mar 16.

Aberrations of EZH2 in cancer.

Clin Cancer Res. 2011 May 1;17(9):2613-8. doi: 10.1158/1078-0432.CCR-10-2156. Epub 2011 Mar 2.

引用本文的文献

Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Curr Cancer Drug Targets. 2013 Jun;13(5):558-79. doi: 10.2174/1568009611313050007.